GLG News Analyses of the following article:

Bausch & Lomb announces acquisition of eyeonics

view article

Published at: www.osnsupersite.com

Steve Rubinstein, Optometrist

Steve RubinsteinOptometristSound Shore Vision Care 
          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Bausch moving forward after takeover by Warburg Pincus

January 29, 2008

The recent purchase by Bausch & Lomb of Eyeonics shows a good move to capture the growing presbyopic correction market. The company has also sent Ronald L. Zarrella to become chairman emeritus. One of the best moves I have heard since the whole Renu problem.

Barry Schechter, Director of Cornea and External Disease

Barry SchechterDirector of Cornea and External DiseaseFLORIDA EYE MICROSURGICAL INSTITUTE INC 
          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

Bausch makes foray into presbyopic arena

January 29, 2008

With the recent trends of presbyopic correction , Bausch and Lomb has now entered the arena.

A MATCH MADE IN HEAVEN.

January 28, 2008

GLG Expert Contributor

I HAVE BEEN PRODICTING THAT A MAJOR PLAYER WOULD BUY EYEONICS SINCE I FIRST STARTED PLACING THE CRYSTALENS IN MY PATIENTS. THE LENS WORKS BUT NEEDED A PRO AT MARKETING. B& L WILL BENIFIT FROM THIS BUY.

Subscribe to Updates

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines

Work for one of the world's leading organizations? Get started now.

Get Intelligently Connected
with the world's leading experts

GLG's 850+ Clients Include:

More than 70% of the world's leading
mutual funds
15 of the leading 20
global banks
9 of the leading 10
global private equity firms
5 of the leading 10
AmLaw firms
Fortune 500® Companies
in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software